FACTANKER · measured, cited, anchored official records connected

SEC EDGAR CompanyFacts fact · point in time

Summit Therapeutics Inc.: cash_and_equivalents

One fact, its scope and the complete path back to the official record.

Period: as of 2019-12-31Status: currentProvenance attached

Cite: FACTANKER, https://factanker.com/fact/55dd35a2-84a4-4379-86f6-a2fc7e04f87a

Reported value

$63.842M{"amount": 63842000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"}
Entity
Summit Therapeutics Inc.
Metric
cash_and_equivalents
Period
as of 2019-12-31
Status
current
Source
SEC EDGAR CompanyFacts

Provenance

Official reference0001599298-20-000039 · Open the official SEC filing →
Source licenseUS-PD-17USC105
Retrieved2026-08-19T16:21:53.979965+02:00
Raw response SHA-256f7bde1a401b286c74a2fd824ee1df541…
Official-identifier pathhttps://factanker.com/fact/sec/cik-0001599298/cash-and-equivalents/2019-12-31 (CIK, metric, reporting date)
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.